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A B S T R A C T
The African swine fever virus DP71L protein recruits protein phosphatase 1 (PP1) to dephosphorylate the
translation initiation factor 2α (eIF2α) and avoid shut-oﬀ of global protein synthesis and downstream activation
of the pro-apoptotic factor CHOP. Residues V16 and F18A were critical for binding of DP71L to PP1. Mutation
of this PP1 binding motif or deletion of residues between 52 and 66 reduced the ability of DP71L to cause
dephosphorylation of eIF2α and inhibit CHOP induction. The residues LSAVL, between 57 and 61, were also
required. PP1 was co-precipitated with wild type DP71L and the mutant lacking residues 52- 66 or the LSAVL
motif, but not with the PP1 binding motif mutant. The residues in the LSAVL motif play a critical role in DP71L
function but do not interfere with binding to PP1. Instead we propose these residues are important for DP71L
binding to eIF2α.
1. Introduction
Many viruses encode proteins that inhibit the shut-oﬀ of global
protein synthesis mediated by the phosphorylation of the eukaryotic
translation initiation factor 2α (eIF2α)⊡ Phosphorylation of eIF2α is
carried out by protein kinases, including the double-stranded RNA
activated protein kinase PKR and endoplasmic reticulum resident (ER)
PERK protein kinase, which is activated as part of the cellular unfolded
protein response (UPR). The UPR is activated following accumulation
of unfolded or misfolded proteins within the ER. The three central
mediators of the UPR; PERK, IRE1 and ATF6, work together to restore
homeostasis within the ER. However, prolonged activation of the UPR
can lead to apoptosis and autophagy (Bernales et al., 2006; Chakrabarti
et al., 2011; Hetz, 2012).
Phosphorylation of translation initiation factor eIF2α on Serine 51,
leads to attenuation of protein synthesis due to the increased aﬃnity of
eIF2α for the guanine nucleotide exchange factor, eIF2B. The inhibi-
tion of eIF2B by eIF2α limits the formation of the pre-initiation
complex, which is required for translation initiation. Since eIF2B is
present in rate-limiting quantities, small changes in the phosphoryla-
tion status of eIF2α can signiﬁcantly aﬀect translation initiation
(Dever, 2002; Krishnamoorthy et al., 2001).
A small subset of stress-related proteins are still synthesised when
eIF2α is phosphorylated. These include the transcription factor ATF4
and downstream targets including the pro-apoptotic transcription
factor CHOP, C/EBP homologous protein (Harding et al., 2000,
2003). CHOP mediates the down-regulation of the anti-apoptotic
protein Bcl2, depletes cellular glutathione and increases production
of reactive oxygen species, sensitising the cell to ER stress and
apoptosis (McCullough et al., 2001).
African swine fever virus (ASFV), is a large cytoplasmic DNA virus
which encodes over 150 proteins, (Dixon et al., 2005). ASFV encodes
DP71L protein, which acts like the host GADD34 (growth arrest and
DNA damage-inducible protein 34) and Herpes simplex virus ICP34.5
protein to recruit PP1, to dephosphorylate eIF2α and so restore protein
synthesis (Brush et al., 2003; Li et al., 2011; Novoa et al., 2001; Zhang
et al., 2008, 2010). ASFV isolates encode either a long (184 amino
acids) or short form 70–72 amino acids) of DP71L. These share a
conserved C-terminal domain with ICP34.5 and GADD34. The addi-
tional N-terminal domain of the long form does not share similarity
with other proteins (Alonso et al., 2013; Rivera et al., 2007). ICP34.5
and GADD34 interact directly with PP1 via a canonical binding
domain, although this interaction alone is not suﬃcient for the
dephosphorylation of eIF2α (He et al., 1997). Residues 233–248 of
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ICP34.5 have been described as containing an eIF2α binding domain
(Li et al., 2011), although the critical interacting residues within this
domain have not been further characterised. The C-terminal domains
of DP71L, ICP34.5 and GADD34 share conserved residues including
the PP1 binding domain (see Fig. 1). Previously (Zhang et al., 2010) we
demonstrated that phosphorylated eIF2α is undetectable in resting
cells expressing DP71L, and this is not increased upon treatment with
ER stress inducers. Interactions between the ASFV homologue DP71L,
PP1 and eIF2α were demonstrated through co-immunoprecipitation
and yeast three-hybrid experiments. We proposed that DP71L recruits
PP1 to dephosphorylate eIF2a, however, the residues involved in these
interactions have not yet been characterised (Rivera et al., 2007; Zhang
et al., 2010). In this study we identiﬁed functionally critical residues in
DP71L, including, a sequence downstream of the PP1 binding domain
which we propose binds to eIF2α. The results provide insights into how
DP71L acts and is of special interest since the 71 amino acid DP71L
protein is the shortest known protein with this function.
2. Results
2.1. DP71L inhibits activation of CHOP induced by tunicamycin
DP71L expression has been shown to result in de-phosphorylation
of eIF2α. This results in inhibition of the downstream induction of
ATF4 and CHOP (Zhang et al., 2010). The ability of mutant forms of
DP71L proteins to inhibit induction of CHOP was therefore used to
identify functionally important residues in the protein. The conditions
for activation of CHOP by tunicamycin in Vero cells were optimized,
and 20 μg/ml tunicamycin treatment for 8 h shown to activate and
induce nuclear localisation of CHOP (data not shown).
Mutants of the DP71L short form protein (DP71Ls) with an N-
terminal HA epitope tag, were constructed and compared with the wild
type protein for the ability to inhibit the induction and nuclear
localisation of CHOP. Initially mutant genes were constructed that
had the predicted PP1 binding site mutated (V16E, F18L, Fig. 1B). In
addition deletions were made of C-terminal sequences. This region is
similar in location, relative to the predicted PP1 binding site, to the
putative eIF2α binding domain of ICP34.5 (residues 233–248 ICP34.5,
Fig. 1A). Following transfection of plasmids expressing these mutant
DP71L proteins into tunicamycin-treated or untreated cells, expression
of CHOP was tested by confocal microscopy (Fig. 2) or by Western
blotting of cell extracts (Fig. 3). A summary of results showing the level
of CHOP induced following transfection of plasmids expressing diﬀer-
ent DP71L mutants into cells is shown in Table 1. Expression of DP71L
protein was detected to varying levels following transfection of all
tested plasmids tested (data not shown and Fig. 3). No expression was
detected from plasmids that encoded DP71L proteins with the C-
terminal 10 or 20 amino acids deleted (data not shown).
Fig. 2 shows representative confocal images for cells expressing
HA-tagged wild type (A) and mutant DP71L proteins including
mutants of residues V16E, F18L (B) and deletion of residues 52–66
(C). The presence of CHOP within the nucleus of 150–200 transfected
cells expressing these mutant proteins was assessed visually. Mutation
of the residues V16E, F18L or deletion of residues 52–66 (Δ 52–66)
resulted in increased numbers of cells expressing CHOP within the
nucleus compared to cells expressing the wild type protein. Cells
expressing mutants DP71L V16E, F18L and DP71L Δ 52–66 demon-
strated inhibition of CHOP nuclear localisation in 17% and 13% of cells
compared to 98% in wild type DP71L expressing cells (Fig. 3 panel B
and C compared to A). The results suggest the residues V16, F18 and
residues 52–66 are required for the inhibition of CHOP induction by
DP71L.
To better deﬁne the regions within the residues 52–66 that are
required to inhibit CHOP activation deletions were made of residues
52–61 (−20 to −10 from the C-terminus) and 57–66 (−15 to −5 from
the C-terminus) (see Fig. 1). A reduction in the eﬃciency of CHOP
inhibition from 98% in cells expressing wild type DP71L to 23% and
18% in cells expressing DP71L Δ 52–61 and DP71L Δ 57–66 was
observed respectively (Table 1). These mutants lack a common motif
(LSAVL) between residues 57–61. A mutant, DP71L Δ LSAVL, lacking
these residues also had a reduced ability to inhibit the accumulation of
CHOP within the nucleus when compared to wild type DP71L (39%
compared to 98% CHOP inhibition) (Table 1).
2.2. The two leucine residues within the LSAVL motif are most
important for DP71L inhibition of CHOP nuclear localisation
Each residue within the LSAVL motif was replaced with an alanine.
Mutating residues S58 and V60 had no eﬀect on the wild type function of
DP71L as CHOP was detected in the nucleus of transfected cells at
similarly high levels as in cells expressing wild type DP71L (Table 1).
Mutation of the two leucine residues to alanine reduced the ability of
DP71L to inhibit CHOP nuclear localisation (Table 1). Of these two
leucine residues mutation of L57 had the greater eﬀect, reducing the
percentage of CHOP inhibition to 31%, compared to 57% for mutant
DP71L L61A, compared to 98% for wild type DP71L (Table 1).
Together, these results suggest that the PP1 binding domain and the
motif LSAVL are critical for function, and of the LSAVL motif the two
Fig. 1. Alignment of DP71L with domains from GADD34 and ICP34.5 and mutants of DP71L Panel A) Shows an alignment of the long and short forms of DP71L with the C terminal
domain of ICP34.5 of HSV-1 and GADD34. Within the C terminal region of ICP34.5 residues 233–248 (green) have been identiﬁed as the eIF2α binding domain (Li et al., 2011), whilst
the eIF2α binding motif described by Rojas et al. (2015) in GADD34 is shown in blue. The predicted PP1 binding motif is highlighted in red. Panel B) shows the sequences of mutants of
DP71L generated in this work. Numbers denote positions within wild type short DP71L sequences that correspond to mutations made. Dashed lines indicate the sequence is not altered
from the wild type sequence and gaps show sequences deleted.
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leucine residues are the most important. DP71L proteins with these
domains mutated retain some ability to inhibit CHOP induction
suggesting additional residues may be important for activity or that
the substitutions did not completely inactivate the protein. Mutants
with both the mutation V16E, F18L and deletion of LSAVL domain were
generated (V16E, F18L ΔLSAVL) and tested for their ability to inhibit
CHOP activation. Mutant DP71L L57, 61A has both the leucine residues
within the LSAVL motif mutated to alanine, whilst mutant DP71L
Fig. 2. The residues V16, F18 and 52–67 are required for function of DP71L. Vero cells were transfected with plasmids expressing HA epitope tagged wild type (A) or mutant DP71L,
panel B, V16E, F18L or lacking residues 52–67 (panel C). At 24 h post-transfection cells were stimulated with 20 µg/ml tunicamycin for 8 h to induce expression of CHOP. Cells were then
ﬁxed in 4% PFA, permeabilised and labelled with DAPI, anti-HA and anti-CHOP antibodies. Primary antibodies were visualised with appropriate secondary reagents conjugated to Alexa
488 or Alexa 568 respectively. Arrows point to the nuclei of transfected cells. Scale bars represent 20 µm.
Fig. 3. Wild type, but not mutant DP71L causes dephosphorylate eIF2α A) Vero cells
were mock-transfected or transfected with wild type or mutant DP71L as indicated on the
ﬁgure. At 24 h post-transfection cells were stimulated with 20 μg/ml tunicamycin for 8 h
and then lysed. 20 μg of total protein from lysates was resolved by SDS-PAGE and
transferred to membranes prior to blotting with antibodies against the HA epitope tag,
phosphorylated and total eIF2α, CHOP and γ tubulin. The positions of molecular mass
markers are indicated to the left of the gel (in Kilo Daltons). B) a) The relative level of
phosphorylated to total eIF2α was determined by densitometry analysis using ImageJ
software, and normalised to the ratio observed in lane 1. b) The relative ratio of CHOP to
total eIF2α was determined as above, and expressed relative to the ratio observed in lane
8. The mean ratio was calculated from three independent experiments.
Table 1
Effect of wild type and mutant forms of DP71L on CHOP induction.
Plasmids expressing wild type or mutant forms of DP71L were transfected into Vero
cells. At 24 h post-transfection cells were stimulated with 20 µg/ml tunicamycin for 8 h
to induce expression of CHOP. Cells were then ﬁxed in 4% PFA, permeabilised and
labelled with DAPI, anti-HA and anti-CHOP antibodies. Confocal microscopy was used to
visualise 150–200 cells expressing the DP71L proteins and determine the percentage of
those in which nuclear localisation of CHOP was induced. The ﬁrst column shows the
DP71L wild type or mutant proteins tested. The second column indicates the numbers of
transfected cells in which CHOP nuclear localisation was detected. The – symbol
indicates none and + or ++ increasing numbers of cells with CHOP detected in the
nucleus. The third column expresses the percentages of transfected cells in which CHOP
was detected in the nucleus.
CHOP Induction % CHOP inhibition
DP71Ls – 98
V16E, F18L ++ 17
Δ52–66 ++ 13
Δ52–61 ++ 23
Δ57–66 ++ 18
ΔLSAVL + 39
L57A + 31
S58A – 98
V60A – 98
L61A +/- 57
L57,61A + 25
V16E, F18L, L57,61A ++ 20
V16E, F18L, ΔLSAVL + 31
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V16E, F18L, L57, 61A lacks both leucine residues and has mutation V16E,
F18L. Finally, mutant DP71L V16E, F18L, Δ LSAVL has the mutation
V16E, F18L, and deletion of the LSAVL motif.
These mutants had reduced ability 20–31% compared to 98%) to
inhibit CHOP nuclear localisation compared to the wild type DP71L
(see Table 1). This suggests that although the V16,F18 residues and
LSAVL sequence have important roles, there are additional residues
required for the ability of DP71L to inhibit CHOP induction.
2.3. Expression of wild type DP71L but not forms mutated in the
V16,F18 residues or LSAVL motif results in dephosphorylation of eIF2α
The inhibition of nuclear localisation of CHOP by wild type DP71L
in cells undergoing ER stress is predicted to be a downstream eﬀect of
the DP71L mediated recruitment of PP1 to dephosphorylate eIF2α.
Therefore, we tested for levels of dephosphorylated eIF2α in cells
transfected with plasmids expressing mutant DP71L proteins.
Plasmids expressing the selected DP71L mutants were transfected
into cells which were treated with tunicamycin, or left untreated.
Western blots of cell lysates were probed with antibodies that
recognised total or phosphorylated eIF2α (38 kDa), CHOP (30 kDa),
the HA epitope-tagged DP71L protein and the loading control γ tubulin
(51 kDa) (see Fig. 3). The levels of expression of wild type DP71L and
the V16E,F18L mutant was consistently higher than that of other
mutants. The mean relative ratio of phosphorylated eIF2α to total
eIF2α and of CHOP to total eIF2α was determined relative to control
Vero cells (see Fig. 3 panel B) from three independent experiments.
In all untreated cells CHOP was not detected but was induced by
tunicamycin treatment. In control cells, as expected, tunicamycin
treatment increased the level of eIF2α phosphorylation compared to
untreated cells. In contrast in cells expressing wild type DP71L the
band corresponding to phosphorylated eIF2α was not detected in
either untreated or tunicamycin-treated cells (Fig. 3 lanes 2 and 9)
although the total level of eIF2α remained stable (compare Fig. 3 lanes
1 and 8). In tunicamycin-treated cells a band corresponding to the
CHOP protein was detected, although reduced in amount relative to
that observed in the untransfected control cells, with a mean relative
ratio of 0.3 compared to 1. In lysates from cells expressing DP71L
which had the V16E, F18L mutation a higher level of eIF2α phosphor-
ylation was detected in both untreated and tunicamycin-treated cells
with relative ratios of 1.3 and 3.4 respectively compared to 1 in control
Vero cells (compare Fig. 3 panel A lanes 3 and 10, and panel B). In
these lysates CHOP was strongly induced following tunicamycin
treatment (Fig. 3 lane 10). In lysates from cells expressing DP71L
Δ52–66 phosphorylated eIF2α was detected in both resting and
tunicamycin-treated cells, indicating that this mutant no longer caused
dephosphorylation of eIF2α. Furthermore, the CHOP protein was
expressed upon stimulation with tunicamycin (Fig. 3 lane 11).
In cells expressing DP71L with mutations in V16E, F18L and the
LSAVL motif the following results were obtained. In lysates of cells
expressing DP71L with a deletion ΔLSAVL, this deletion in combina-
tion with V16E, F18L, Δ LSAVL, and V16E, F18L, L57, 61A phosphory-
lated eIF2α was detected in untreated cells, and increased following
tunicamycin treatment (compare Fig. 3 lanes 5–7 and 12–14). The
CHOP protein was also detected in tunicamycin-treated cells expres-
sing DP71L mutants with the LSAVL sequence deleted (ΔLSAVL), with
V16E, F18L, mutated in combination with the LSAVL sequence mutated
(V16E, F18L, L57, 61A) and with the mutated in combination with the
LSAVL sequence deleted (V16E, F18L, ΔLSAVL).
Interestingly, lysates from cells expressing DP71L Δ52–66 had the
highest relative ratio between phosphorylated and total eIF2α in the
untreated cell lysates (Fig. 3 A lane 4, 1.8 to 1) and was also higher in
the tunicamycin-treated cells (Fig. 3 A lane 11, 3.6 to 2.3) compared to
other mutants tested. This mutant form of DP71L may still bind PP1
and thus sequester PP1 preventing its interaction with cellular factors
which control the level of eIF2α phosphorylation. This could explain
the observed increase in the level of phosphorylated eIF2α in cells
expressing this DP71L mutant.
The data conﬁrmed that mutation of the V16, F18 residues or LSAVL
motif in DP71L resulted in the loss of wild type DP71L ability to cause
dephosphorylation of eIF2α and inhibit induction of CHOP following
tunicamycin treatment.
2.4. DP71L mutants with mutations in residues V16, F18 do not co-
precipitate with PP1
Our previous results using the yeast three hybrid system indicated
that DP71L binds to PP1 and this complex interacts with eIF2α (Zhang
et al., 2010). A prediction from this is that mutation of the PP1 binding
domain in DP71L would reduce the interaction between these proteins
and the failure to recruit PP1 to eIF2α would explain the failure to
inhibit eIF2α phosphorylation. Levels of the wild type and mutant
DP71L detected in total lysates detected by Western blotting varied
(Fig. 3). The wild type DP71L, V16E, F18L, and this mutation combined
with a deletion of the LSAVL sequence (V16E, F18L, ΔLSAVL) were
expressed at highest levels. Anti-HA was used to precipitate DP71L and
interacting proteins from cell lysates. The co-precipitates were resolved
by SDS/PAGE and Western blotting carried out with antibodies to PP1
and anti-HA (Fig. 4). As expected, PP1 was strongly co-precipitated
from cells expressing wild type DP71L (Fig. 4. lane 8). PP1 was not co-
precipitated with the mutant DP71L V16E, F18L, indicating that these
residues are critical for the interaction between DP71L and PP1 (Fig. 4,
lane 9). PP1 was co-precipitated with mutant DP71L Δ LSAVL (Fig. 4
lane 10). Thus the ΔLSAVL mutants still co-precipitated with PP1
indicating these residues are not critical for this interaction.
The interaction of wild type DP71L and the PP1 binding mutant
DP71L V16A, F18L with all three isoforms of PP1 was investigated
using the yeast two-hybrid system. As shown in Fig. 5 the wild type
DP71L interacted strongly with the α, and β ιsoforms of PP1, and also
interacted with the γ isoform (albeit more weakly, since the interaction
was weak in the presence of 10 mM 3-aminotriazole). In contrast the
DP71L V16E, F18A did not bind to any of the isoforms even at low
stringency.
2.5. Wild type, but not mutant, DP71L acts as a translation enhancer
To assess whether the DP71L mutants which had reduced ability to
dephosphorylate eIF2α had also lost their ability to act as translation
enhancers, a bi-cistronic reporter plasmid was used with the ﬁreﬂy
luciferase gene downstream of the CMV promoter and the renilla
luciferase gene downstream of the ECMV IRES. Using this reporter
plasmid, both cap-dependent and independent translation initiation
Fig. 4. DP71L mutant V16E, F18L does not co-precipitate with PP1 Vero cells were
transfected with plasmids expressing wild type or mutant DP71L, 24 h post-transfection
lysates were harvested and incubated overnight with the HA aﬃnity matrix at 4 °C with
rotation. Lysates were pelleted and washed three times prior to re-suspension in SDS-
PAGE loading buﬀer. Samples were resolved by SDS-PAGE, transferred to membranes by
Western blot and probed against the HA epitope tag and PP1.
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can be assessed by measuring levels of ﬁreﬂy and renilla luciferase
respectively. It is predicted that DP71L would enhance both cap
dependent and independent translation, as eIF2α is required for
translation initiation of both.
Vero cells were co-transfected with equal amounts of the bi-
cistronic reporter plasmid and pcDNA3 expressing wild type or mutant
DP71L or empty vector. The reporter activity of control cells trans-
fected with pcDNA3 was set at 100% and the activity in cells
transfected with wild type or mutant DP71L expressed as a percentage
relative to pcDNA3. Fig. 6 shows that DP71L eﬃciently enhanced
translation of both cap-dependent and independent translation by over
450% of the pcDNA3 control for ﬁreﬂy luciferase cap dependent
translation (panel A), and just under 300% for renilla luciferase cap
independent translation (panel B). In contrast, all of the DP71L
mutants tested abolished this enhancement, as the levels of reporter
expression were similar to the plasmid control. By performing a one
way ANOVA in GraphPad Prism with multiple comparisons test against
wild type DP71L, it was established that each of the mutants
signiﬁcantly reduced the translation enhancer eﬀect of DP71L
(P≤0.0001).
Plasmids expressing mutants DP71L Δ52-66 and DP71L Δ LSAVL
consistently displayed a reduced induction of reporter activity com-
pared to the pcDNA3 control plasmid, and this reached statistical
signiﬁcance for the DP71L mutant Δ LSAVL, (P value of < 0.05 see
Fig. 6, blue asterisk). Possibly because these DP71L mutants still bind
PP1 they may sequester PP1 from cellular factors such as CReP,
reducing de-phosphorylation of eIF2α, and so decreasing translation
below basal conditions.
3. Discussion
Shut-oﬀ of host protein synthesis is a major limitation to viral
replication, and as such many viruses, including ASFV, have evolved
mechanisms to evade or limit this response. The DP71L protein acts by
targeting the cellular phosphatase PP1 to dephosphorylate translation
initiation factor eIF2α to avoid the shut-oﬀ of global protein synthesis.
This may be induced by either the double-stranded RNA activated
protein kinase PKR or the protein kinase-like ER resident kinase
(PERK), which is activated as part of the unfolded protein response
(UPR). The UPR also feeds into the innate immune response through
the activation of pro-inﬂammatory cytokines and NF-κB. This occurs
via the IRE1/XBP1 and PERK pathways, as for example, IL-6 and IL-8
are targets of XBP1, whilst the shut oﬀ of protein synthesis by PERK
leads to an imbalance in the ratio of IκB to NF-κB, leading to NF-κB
activation (Deng et al., 2004; Gargalovic et al., 2006; Kaneko et al.,
Fig. 5. The V16E; F18L form of DP71L is unable to interact with protein phosphatase
isoforms Panel B. Yeast strain PJ69-4α was transformed with pairs of plasmids
expressing the indicated DNA binding hybrid and the phosphatase (PPC1) isoform fused
to the yeast GAL4 activation domain. Yeast containing both plasmids were selected on
synthetic drop-out medium lacking leucine and tryptophan (“-LW”) and then streaked
onto synthetic drop-out medium lacking leucine, tryptophan and histidine and contain-
ing 5mJM or 10 mM 3-aminotriazole (“-LWH +3AT”). Growth on the latter is indicative
of protein-protein interaction.
Fig. 6. Wild type, but not mutant, DP71L acts as a translation enhancer Vero cells were
co-transfected with equal amounts of the bi-cistronic reporter plasmid pIRES FF luc/Ren
luc and pcDNA3, wild type or mutant DP71L as indicated. 24 h post-transfection cells
were lysed and reporter activity assessed using the Dual-Luciferase Reporter Assay kit
(Promega). The ﬁreﬂy (A) or renilla (B) reporter activity of control cells transfected with
pcDNA3 was set at 100% and wild type or mutant activity expressed as a percentage
relative to pcDNA3. Experiments were performed in triplicate three times. Error bars
represent the standard deviation. Statistical analysis was carried out in GraphPad Prism
using a one way ANOVA with multiple comparisons test. Asterisks represent a signiﬁcant
diﬀerence in value between WT DP71L and the mutants tested (*= P value of < 0.5,
****= P value of < 0.0001).
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2003; Urano et al., 2000). In previous studies ASFV infection of Vero
cells was shown to activate the ATF6 branch (ATF6 activates ER
chaperones and XBP1) of the UPR but not PERK or the inositol-
requiring enzyme (IRE1) (Galindo et al., 2012; Netherton et al., 2004).
This evidence suggests that ASFV infection does not cause PERK
activation and thus DP71L function may primarily function to counter-
act PKR-activated phosphorylation of eIF2α.
In this study we identiﬁed critical residues which are required for
function of DP71L to reduce phosphorylation of translation initiation
factor eIF2α and to inhibit the downstream eﬀects including induction
of the pro-apoptotic CHOP protein in response to stress induced by
tunicamycin. We conﬁrmed that the residues V16, F18 within a
predicted PP1 binding site (VRF) in DP71L were required for these
functions. We showed that wild type DP71L co-precipitated with PP1
whereas DP71L with a mutation V16E, F18L did not. Thus we conclude
that these residues are essential for PP1 binding and function of
DP71L.
We expected to identify a domain in DP71L required for binding to
eIF2α and investigated whether sequences downstream from the PP1
binding domain were required for DP71L function. Mutation of the
sequence LSAVL between residues 57 and 61 reduced DP71L ability to
cause dephosphorylation of eIF2α and inhibit CHOP induction. Within
this LSAVL sequence the two leucine residues were most critical.
DP71L mutants of the LSAVL sequence retained the ability to co-
precipitate PP1 suggesting that the LSAVL sequence has a critical
functional role other than PP1 binding. We failed to detect co-
precipitation of eIF2α with DP71L and PP1, possibly due to a weak
or transitory interaction (data not shown). Therefore we were unable to
conﬁrm that this sequence is involved in binding of DP71L to eIF2α
although consider this likely.
Studies with ICP34.5 and GADD34 proteins have also investigated
domains critical for function. In one study (Li et al., 2011) the eIF2α
binding domain of ICP34.5 was mapped to residues 233–248; and in
GADD34 the sequence between residues 578–597, Rx[Gnl]x1-
2Wxxx[Arlv]x[Dn][Rg]xRFxx[Rlvk][Ivc] (where capital letters are pre-
ferred and x is any residue) was described (Rojas et al., 2015) as the
eIF2α binding (see Fig. 1). Further investigation of residues in this
sequence critical for DP71L function would be of interest. In ICP34.5
and GADD34 an additional RARA motif has been implicated in
stabilising PP1 binding (Brush et al., 2003; Zhang et al., 2008). A
similar sequence is not present in either the long form or short form of
DP71L.
It is interesting that the leucine residues within the DP71L LSAVL
sequence are highly conserved between ICP34.5, GADD34 and DP71L
supporting the hypothesis that these amino acids are indeed involved
in an interaction with eIF2α. Structure prediction analysis also
suggests that these residues are highly exposed.
4. Materials and methods
4.1. Plasmids
Wild type or mutant DP71L genes were synthesised with an HA-tag
of sequence YPYDVPDYA (Euroﬁns, London, UK) fused at the 5′ end of
the gene. Genes were subsequently subcloned into the pEF-plink2
vector using the Nco I and Xba I restriction sites, and into pcDNA3
using the Hind III and Bam HI restriction sites. The plasmid pIRES FF
luc/Ren luc was generated by inserting the ﬁreﬂy luciferase gene
between the Xho I and Mlu I restriction sites, and the renilla luciferase
gene between Xba I and Not I restriction sites of pIRES Neo.
4.2. Cell culture and transfection
Vero cells were maintained in Dulbecco's modiﬁed Eagle's medium
(DMEM) containing 10% foetal bovine serum, penicillin (100 IU/ml)
and streptomycin (100 μg/ml). Cells were seeded at 2.5×104 cells/cm2
16 h prior to transfection or experimental treatment. Transfections
were performed in accordance with the TransIT-LT1 transfection
reagent protocol (Mirus, USA). When required, cells were treated with
tunicamycin, by replacing the culture media with media containing
20 μg/ml tunicamycin for 8 h, prior to harvesting for assay.
4.3. Luciferase assays
Lysates were prepared from cells that had been co-transfected with
the reporter plasmid pIRES FF luc/Ren luc and control plasmids, or
plasmids expressing either wild type or mutant DP71L. Lysates were
analysed for luciferase activity using the dual luciferase reporter assay
kit (Promega, UK), in accordance with the manufacturer's instructions.
4.4. Antibodies
Antibodies used included a mouse monoclonal against CHOP (B3,
Santa Cruz, USA) used at a 1:200 dilution for confocal microscopy and
Western blotting, a goat monoclonal against total eIF2α (K17, Santa
Cruz) and a rabbit monoclonal against phosphorylated eIF2α (E90,
Abcam, UK) used at 1:1000 and 1:500 for Western blotting respec-
tively. The rat anti-HA antibody was from Roche (clone 3F10) and was
used at a 1:500 dilution for confocal microscopy, and 1:1000 for
Western blot. The goat polyclonal antibody against PP1 was acquired
from Santa Cruz, USA (clone C19) and used at a dilution of 1:1000 for
Western blot. The γ tubulin antibody (Sigma-Aldrich, T6557) was used
at a 1:25,000 dilution for Western blot.
The following horseradish peroxidase (HRP) conjugated secondary
antibodies were used for Western blotting at a 1:1000 dilution and
were acquired from Dako, UK; rabbit anti-rat HRP (P0450), rabbit
anti-mouse HRP (P0260), goat anti-rabbit HRP (P0448). In addition,
the bovine anti-goat HRP antibody (Santa Cruz, USA sc-2384) was
used at a 1:5000 dilution. The HA-HRP conjugated antibody (Roche,
3F10) was used at a 1:1000 dilution. Alexa Fluor antibodies goat anti-
rat 488 and rabbit anti-mouse 568 were used at a 1:500 dilution for
confocal microscopy.
4.5. SDS-PAGE and Western blotting
Cell lysates were harvested in RIPA buﬀer (Sigma) containing
protease inhibitors (Sigma). The protein content was determined using
the Pierce™ BCA Protein Assay Kit (Thermo-Fisher Scientiﬁc) and
subsequently normalised, such that 10 or 20 µg of total protein could
be loaded, per lane, onto SDS-PAGE gels. Proteins were resolved by
SDS-PAGE and then transferred to Hybond PVDF membranes (GE
Healthcare). Membranes were incubated for 1 h in PBS, 0.2% Tween-
20, 5% skimmed milk powder, prior to an overnight incubation with
the primary antibody diluted in the same blocking buﬀer. Membranes
were washed in PBS containing 0.2% Tween-20, before incubating for
1 h with the HRP-conjugated secondary antibody. Membranes were
washed prior to detection of chemiluminescence by incubating the
membrane with LumiGLO (Cell Signalling Technology) for 1 min.
Membranes were then exposed to X-ray ﬁlm (Fujiﬁlm) and developed
manually using developer and ﬁxer from AGFA.
4.6. Confocal microscopy
Cells were seeded onto glass coverslips (VWR) prior to transfection
or other relevant treatment. At the experimental end-point, cells were
washed with PBS (Gibco Thermo-Fisher Scientiﬁc), and ﬁxed with 4%
paraformaldehyde (PFA) for 1 h. Cells were permeabilised by incuba-
tion with PBS +0.1% Triton X-100 (Sigma-Aldrich) for 15 min,
followed by blocking for 30 min with 0.5% BSA (Sigma-Aldrich) prior
to antibody staining for 1 h with primary antibodies. Following several
washes, coverslips were incubated with secondary antibodies for a
further hour. Coverslips were washed, and DNA counterstained with
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DAPI (4′, 6-Diamidino-2-Phenylindole, Dihydrochrolide) prior to
mounting. Cells were visualised using a Leica confocal laser scanning
microscope, and data analysed using LCS Lite or LASAF Lite (Leica
Confocal Software). Merged images were created in Image J.
4.7. Co-immunoprecipitation
Cells expressing HA-tagged wild type or mutant DP71L, and control
non-transfected cells, were lysed in Pierce Protein Biology, Thermo
Fisher Scientiﬁc IP lysis buﬀer supplemented with protease inhibitors.
The lysate was incubated with anti-HA aﬃnity matrix (Roche) over-
night with rotation. The matrix was washed three times followed by
centrifugation prior to resuspending the matrix in lysis buﬀer adding 5
x SDS-PAGE loading buﬀer. Samples were then boiled for 2 min, and
the proteins resolved by SDS-PAGE then transferred to PVDF mem-
branes (GE Healthcare) before Western blotting using primary and
secondary antibodies as described.
4.8. Yeast two-hybrid
Combinations of GAL4 DBD and GAL4AD fusion plasmids were
introduced into Saccharomyces cerevisiae strain PJ69-4α as described
in Zhang et al. (2010) and selected on synthetic dropout medium
lacking leucine and tryptophan. Individual colonies were subsequently
streaked onto medium also lacking histidine and containing 5 mM or
10 mM 3-aminotriazole. Growth was monitored for 7 days at 30 °C.
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